img

Global Valsartan Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Valsartan Market Insights, Forecast to 2034

The global Valsartan market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Valsartan is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Valsartan is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Valsartan is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of Valsartan include Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma, Macleods Pharmaceuticals and HETERO, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for Valsartan, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Valsartan, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Valsartan, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Valsartan sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global Valsartan market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for Valsartan sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma, Macleods Pharmaceuticals and HETERO, etc.



By Company


Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories
LG Life Sciences
Segment by Type
40 mg Tablets
80 mg Tablets
160 mg Tablets
320 mg Tablets

Segment by Application


Hypertension
Heart Failure
Heart Attack

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Valsartan in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Valsartan manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Valsartan sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Valsartan Product Introduction
1.2 Market by Type
1.2.1 Global Valsartan Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 40 mg Tablets
1.2.3 80 mg Tablets
1.2.4 160 mg Tablets
1.2.5 320 mg Tablets
1.3 Market by Application
1.3.1 Global Valsartan Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hypertension
1.3.3 Heart Failure
1.3.4 Heart Attack
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Valsartan Sales Estimates and Forecasts 2018-2034
2.2 Global Valsartan Revenue by Region
2.2.1 Global Valsartan Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Valsartan Revenue by Region (2018-2024)
2.2.3 Global Valsartan Revenue by Region (2024-2034)
2.2.4 Global Valsartan Revenue Market Share by Region (2018-2034)
2.3 Global Valsartan Sales Estimates and Forecasts 2018-2034
2.4 Global Valsartan Sales by Region
2.4.1 Global Valsartan Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Valsartan Sales by Region (2018-2024)
2.4.3 Global Valsartan Sales by Region (2024-2034)
2.4.4 Global Valsartan Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Valsartan Sales by Manufacturers
3.1.1 Global Valsartan Sales by Manufacturers (2018-2024)
3.1.2 Global Valsartan Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Valsartan in 2022
3.2 Global Valsartan Revenue by Manufacturers
3.2.1 Global Valsartan Revenue by Manufacturers (2018-2024)
3.2.2 Global Valsartan Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Valsartan Revenue in 2022
3.3 Global Key Players of Valsartan, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Valsartan Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Valsartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Valsartan, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Valsartan, Product Offered and Application
3.8 Global Key Manufacturers of Valsartan, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Valsartan Sales by Type
4.1.1 Global Valsartan Historical Sales by Type (2018-2024)
4.1.2 Global Valsartan Forecasted Sales by Type (2024-2034)
4.1.3 Global Valsartan Sales Market Share by Type (2018-2034)
4.2 Global Valsartan Revenue by Type
4.2.1 Global Valsartan Historical Revenue by Type (2018-2024)
4.2.2 Global Valsartan Forecasted Revenue by Type (2024-2034)
4.2.3 Global Valsartan Revenue Market Share by Type (2018-2034)
4.3 Global Valsartan Price by Type
4.3.1 Global Valsartan Price by Type (2018-2024)
4.3.2 Global Valsartan Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Valsartan Sales by Application
5.1.1 Global Valsartan Historical Sales by Application (2018-2024)
5.1.2 Global Valsartan Forecasted Sales by Application (2024-2034)
5.1.3 Global Valsartan Sales Market Share by Application (2018-2034)
5.2 Global Valsartan Revenue by Application
5.2.1 Global Valsartan Historical Revenue by Application (2018-2024)
5.2.2 Global Valsartan Forecasted Revenue by Application (2024-2034)
5.2.3 Global Valsartan Revenue Market Share by Application (2018-2034)
5.3 Global Valsartan Price by Application
5.3.1 Global Valsartan Price by Application (2018-2024)
5.3.2 Global Valsartan Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Valsartan Market Size by Type
6.1.1 US & Canada Valsartan Sales by Type (2018-2034)
6.1.2 US & Canada Valsartan Revenue by Type (2018-2034)
6.2 US & Canada Valsartan Market Size by Application
6.2.1 US & Canada Valsartan Sales by Application (2018-2034)
6.2.2 US & Canada Valsartan Revenue by Application (2018-2034)
6.3 US & Canada Valsartan Market Size by Country
6.3.1 US & Canada Valsartan Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Valsartan Sales by Country (2018-2034)
6.3.3 US & Canada Valsartan Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Valsartan Market Size by Type
7.1.1 Europe Valsartan Sales by Type (2018-2034)
7.1.2 Europe Valsartan Revenue by Type (2018-2034)
7.2 Europe Valsartan Market Size by Application
7.2.1 Europe Valsartan Sales by Application (2018-2034)
7.2.2 Europe Valsartan Revenue by Application (2018-2034)
7.3 Europe Valsartan Market Size by Country
7.3.1 Europe Valsartan Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Valsartan Sales by Country (2018-2034)
7.3.3 Europe Valsartan Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Valsartan Market Size
8.1.1 China Valsartan Sales (2018-2034)
8.1.2 China Valsartan Revenue (2018-2034)
8.2 China Valsartan Market Size by Application
8.2.1 China Valsartan Sales by Application (2018-2034)
8.2.2 China Valsartan Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Valsartan Market Size by Type
9.1.1 Asia Valsartan Sales by Type (2018-2034)
9.1.2 Asia Valsartan Revenue by Type (2018-2034)
9.2 Asia Valsartan Market Size by Application
9.2.1 Asia Valsartan Sales by Application (2018-2034)
9.2.2 Asia Valsartan Revenue by Application (2018-2034)
9.3 Asia Valsartan Sales by Region
9.3.1 Asia Valsartan Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Valsartan Revenue by Region (2018-2034)
9.3.3 Asia Valsartan Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Valsartan Market Size by Type
10.1.1 Middle East, Africa and Latin America Valsartan Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Valsartan Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Valsartan Market Size by Application
10.2.1 Middle East, Africa and Latin America Valsartan Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Valsartan Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Valsartan Sales by Country
10.3.1 Middle East, Africa and Latin America Valsartan Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Valsartan Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Valsartan Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novartis Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Information
11.2.2 Sun Pharmaceutical Overview
11.2.3 Sun Pharmaceutical Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sun Pharmaceutical Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sun Pharmaceutical Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Teva Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Mylan Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Alembic Pharmaceuticals
11.5.1 Alembic Pharmaceuticals Company Information
11.5.2 Alembic Pharmaceuticals Overview
11.5.3 Alembic Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Alembic Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Alembic Pharmaceuticals Recent Developments
11.6 Lupin
11.6.1 Lupin Company Information
11.6.2 Lupin Overview
11.6.3 Lupin Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Lupin Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lupin Recent Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Information
11.7.2 Aurobindo Pharma Overview
11.7.3 Aurobindo Pharma Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Aurobindo Pharma Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aurobindo Pharma Recent Developments
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Information
11.8.2 Macleods Pharmaceuticals Overview
11.8.3 Macleods Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Macleods Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Macleods Pharmaceuticals Recent Developments
11.9 HETERO
11.9.1 HETERO Company Information
11.9.2 HETERO Overview
11.9.3 HETERO Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 HETERO Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 HETERO Recent Developments
11.10 Torrent Pharmaceuticals
11.10.1 Torrent Pharmaceuticals Company Information
11.10.2 Torrent Pharmaceuticals Overview
11.10.3 Torrent Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Torrent Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Torrent Pharmaceuticals Recent Developments
11.11 Huaren Pharmaceutical
11.11.1 Huaren Pharmaceutical Company Information
11.11.2 Huaren Pharmaceutical Overview
11.11.3 Huaren Pharmaceutical Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Huaren Pharmaceutical Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Huaren Pharmaceutical Recent Developments
11.12 Jubilant Pharma
11.12.1 Jubilant Pharma Company Information
11.12.2 Jubilant Pharma Overview
11.12.3 Jubilant Pharma Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Jubilant Pharma Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Jubilant Pharma Recent Developments
11.13 Amneal Pharmaceuticals
11.13.1 Amneal Pharmaceuticals Company Information
11.13.2 Amneal Pharmaceuticals Overview
11.13.3 Amneal Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Amneal Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Amneal Pharmaceuticals Recent Developments
11.14 Zhejiang Huahai Pharmaceutical
11.14.1 Zhejiang Huahai Pharmaceutical Company Information
11.14.2 Zhejiang Huahai Pharmaceutical Overview
11.14.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Zhejiang Huahai Pharmaceutical Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Zhejiang Huahai Pharmaceutical Recent Developments
11.15 Square Pharmaceuticals
11.15.1 Square Pharmaceuticals Company Information
11.15.2 Square Pharmaceuticals Overview
11.15.3 Square Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Square Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Square Pharmaceuticals Recent Developments
11.16 Unichem Laboratories
11.16.1 Unichem Laboratories Company Information
11.16.2 Unichem Laboratories Overview
11.16.3 Unichem Laboratories Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Unichem Laboratories Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Unichem Laboratories Recent Developments
11.17 LG Life Sciences
11.17.1 LG Life Sciences Company Information
11.17.2 LG Life Sciences Overview
11.17.3 LG Life Sciences Valsartan Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 LG Life Sciences Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 LG Life Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Valsartan Industry Chain Analysis
12.2 Valsartan Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Valsartan Production Mode & Process
12.4 Valsartan Sales and Marketing
12.4.1 Valsartan Sales Channels
12.4.2 Valsartan Distributors
12.5 Valsartan Customers
13 Market Dynamics
13.1 Valsartan Industry Trends
13.2 Valsartan Market Drivers
13.3 Valsartan Market Challenges
13.4 Valsartan Market Restraints
14 Key Findings in The Global Valsartan Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Valsartan Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 40 mg Tablets
Table 3. Major Manufacturers of 80 mg Tablets
Table 4. Major Manufacturers of 160 mg Tablets
Table 5. Major Manufacturers of 320 mg Tablets
Table 6. Global Valsartan Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Valsartan Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Valsartan Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Valsartan Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Valsartan Revenue Market Share by Region (2018-2024)
Table 11. Global Valsartan Revenue Market Share by Region (2024-2034)
Table 12. Global Valsartan Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 13. Global Valsartan Sales by Region (2018-2024) & (K Units)
Table 14. Global Valsartan Sales by Region (2024-2034) & (K Units)
Table 15. Global Valsartan Sales Market Share by Region (2018-2024)
Table 16. Global Valsartan Sales Market Share by Region (2024-2034)
Table 17. Global Valsartan Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Valsartan Sales Share by Manufacturers (2018-2024)
Table 19. Global Valsartan Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Valsartan Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Valsartan, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Valsartan Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Valsartan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Valsartan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valsartan as of 2022)
Table 25. Global Key Manufacturers of Valsartan, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Valsartan, Product Offered and Application
Table 27. Global Key Manufacturers of Valsartan, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Valsartan Sales by Type (2018-2024) & (K Units)
Table 30. Global Valsartan Sales by Type (2024-2034) & (K Units)
Table 31. Global Valsartan Sales Share by Type (2018-2024)
Table 32. Global Valsartan Sales Share by Type (2024-2034)
Table 33. Global Valsartan Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Valsartan Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Valsartan Revenue Share by Type (2018-2024)
Table 36. Global Valsartan Revenue Share by Type (2024-2034)
Table 37. Valsartan Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Valsartan Price Forecast by Type (2024-2034) & (US$/Unit)
Table 39. Global Valsartan Sales by Application (2018-2024) & (K Units)
Table 40. Global Valsartan Sales by Application (2024-2034) & (K Units)
Table 41. Global Valsartan Sales Share by Application (2018-2024)
Table 42. Global Valsartan Sales Share by Application (2024-2034)
Table 43. Global Valsartan Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Valsartan Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Valsartan Revenue Share by Application (2018-2024)
Table 46. Global Valsartan Revenue Share by Application (2024-2034)
Table 47. Valsartan Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Valsartan Price Forecast by Application (2024-2034) & (US$/Unit)
Table 49. US & Canada Valsartan Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Valsartan Sales by Type (2024-2034) & (K Units)
Table 51. US & Canada Valsartan Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Valsartan Revenue by Type (2024-2034) & (US$ Million)
Table 53. US & Canada Valsartan Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Valsartan Sales by Application (2024-2034) & (K Units)
Table 55. US & Canada Valsartan Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Valsartan Revenue by Application (2024-2034) & (US$ Million)
Table 57. US & Canada Valsartan Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. US & Canada Valsartan Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Valsartan Revenue by Country (2024-2034) & (US$ Million)
Table 60. US & Canada Valsartan Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Valsartan Sales by Country (2024-2034) & (K Units)
Table 62. Europe Valsartan Sales by Type (2018-2024) & (K Units)
Table 63. Europe Valsartan Sales by Type (2024-2034) & (K Units)
Table 64. Europe Valsartan Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Valsartan Revenue by Type (2024-2034) & (US$ Million)
Table 66. Europe Valsartan Sales by Application (2018-2024) & (K Units)
Table 67. Europe Valsartan Sales by Application (2024-2034) & (K Units)
Table 68. Europe Valsartan Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Valsartan Revenue by Application (2024-2034) & (US$ Million)
Table 70. Europe Valsartan Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 71. Europe Valsartan Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Valsartan Revenue by Country (2024-2034) & (US$ Million)
Table 73. Europe Valsartan Sales by Country (2018-2024) & (K Units)
Table 74. Europe Valsartan Sales by Country (2024-2034) & (K Units)
Table 75. China Valsartan Sales by Type (2018-2024) & (K Units)
Table 76. China Valsartan Sales by Type (2024-2034) & (K Units)
Table 77. China Valsartan Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Valsartan Revenue by Type (2024-2034) & (US$ Million)
Table 79. China Valsartan Sales by Application (2018-2024) & (K Units)
Table 80. China Valsartan Sales by Application (2024-2034) & (K Units)
Table 81. China Valsartan Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Valsartan Revenue by Application (2024-2034) & (US$ Million)
Table 83. Asia Valsartan Sales by Type (2018-2024) & (K Units)
Table 84. Asia Valsartan Sales by Type (2024-2034) & (K Units)
Table 85. Asia Valsartan Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Valsartan Revenue by Type (2024-2034) & (US$ Million)
Table 87. Asia Valsartan Sales by Application (2018-2024) & (K Units)
Table 88. Asia Valsartan Sales by Application (2024-2034) & (K Units)
Table 89. Asia Valsartan Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Valsartan Revenue by Application (2024-2034) & (US$ Million)
Table 91. Asia Valsartan Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 92. Asia Valsartan Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Valsartan Revenue by Region (2024-2034) & (US$ Million)
Table 94. Asia Valsartan Sales by Region (2018-2024) & (K Units)
Table 95. Asia Valsartan Sales by Region (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Valsartan Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Valsartan Sales by Type (2024-2034) & (K Units)
Table 98. Middle East, Africa and Latin America Valsartan Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Valsartan Revenue by Type (2024-2034) & (US$ Million)
Table 100. Middle East, Africa and Latin America Valsartan Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Valsartan Sales by Application (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Valsartan Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Valsartan Revenue by Application (2024-2034) & (US$ Million)
Table 104. Middle East, Africa and Latin America Valsartan Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 105. Middle East, Africa and Latin America Valsartan Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Valsartan Revenue by Country (2024-2034) & (US$ Million)
Table 107. Middle East, Africa and Latin America Valsartan Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Valsartan Sales by Country (2024-2034) & (K Units)
Table 109. Novartis Company Information
Table 110. Novartis Description and Major Businesses
Table 111. Novartis Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Novartis Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Novartis Recent Developments
Table 114. Sun Pharmaceutical Company Information
Table 115. Sun Pharmaceutical Description and Major Businesses
Table 116. Sun Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Sun Pharmaceutical Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Sun Pharmaceutical Recent Developments
Table 119. Teva Company Information
Table 120. Teva Description and Major Businesses
Table 121. Teva Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Teva Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Teva Recent Developments
Table 124. Mylan Company Information
Table 125. Mylan Description and Major Businesses
Table 126. Mylan Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Mylan Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Mylan Recent Developments
Table 129. Alembic Pharmaceuticals Company Information
Table 130. Alembic Pharmaceuticals Description and Major Businesses
Table 131. Alembic Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Alembic Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Alembic Pharmaceuticals Recent Developments
Table 134. Lupin Company Information
Table 135. Lupin Description and Major Businesses
Table 136. Lupin Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Lupin Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Lupin Recent Developments
Table 139. Aurobindo Pharma Company Information
Table 140. Aurobindo Pharma Description and Major Businesses
Table 141. Aurobindo Pharma Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Aurobindo Pharma Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Aurobindo Pharma Recent Developments
Table 144. Macleods Pharmaceuticals Company Information
Table 145. Macleods Pharmaceuticals Description and Major Businesses
Table 146. Macleods Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Macleods Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Macleods Pharmaceuticals Recent Developments
Table 149. HETERO Company Information
Table 150. HETERO Description and Major Businesses
Table 151. HETERO Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. HETERO Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. HETERO Recent Developments
Table 154. Torrent Pharmaceuticals Company Information
Table 155. Torrent Pharmaceuticals Description and Major Businesses
Table 156. Torrent Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Torrent Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Torrent Pharmaceuticals Recent Developments
Table 159. Huaren Pharmaceutical Company Information
Table 160. Huaren Pharmaceutical Description and Major Businesses
Table 161. Huaren Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Huaren Pharmaceutical Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Huaren Pharmaceutical Recent Developments
Table 164. Jubilant Pharma Company Information
Table 165. Jubilant Pharma Description and Major Businesses
Table 166. Jubilant Pharma Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Jubilant Pharma Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Jubilant Pharma Recent Developments
Table 169. Amneal Pharmaceuticals Company Information
Table 170. Amneal Pharmaceuticals Description and Major Businesses
Table 171. Amneal Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Amneal Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Amneal Pharmaceuticals Recent Developments
Table 174. Zhejiang Huahai Pharmaceutical Company Information
Table 175. Zhejiang Huahai Pharmaceutical Description and Major Businesses
Table 176. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Zhejiang Huahai Pharmaceutical Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Zhejiang Huahai Pharmaceutical Recent Developments
Table 179. Square Pharmaceuticals Company Information
Table 180. Square Pharmaceuticals Description and Major Businesses
Table 181. Square Pharmaceuticals Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Square Pharmaceuticals Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Square Pharmaceuticals Recent Developments
Table 184. Unichem Laboratories Company Information
Table 185. Unichem Laboratories Description and Major Businesses
Table 186. Unichem Laboratories Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. Unichem Laboratories Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Unichem Laboratories Recent Developments
Table 189. LG Life Sciences Company Information
Table 190. LG Life Sciences Description and Major Businesses
Table 191. LG Life Sciences Valsartan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 192. LG Life Sciences Valsartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 193. LG Life Sciences Recent Developments
Table 194. Key Raw Materials Lists
Table 195. Raw Materials Key Suppliers Lists
Table 196. Valsartan Distributors List
Table 197. Valsartan Customers List
Table 198. Valsartan Market Trends
Table 199. Valsartan Market Drivers
Table 200. Valsartan Market Challenges
Table 201. Valsartan Market Restraints
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Valsartan Product Picture
Figure 2. Global Valsartan Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Valsartan Market Share by Type in 2022 & 2034
Figure 4. 40 mg Tablets Product Picture
Figure 5. 80 mg Tablets Product Picture
Figure 6. 160 mg Tablets Product Picture
Figure 7. 320 mg Tablets Product Picture
Figure 8. Global Valsartan Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Valsartan Market Share by Application in 2022 & 2034
Figure 10. Hypertension
Figure 11. Heart Failure
Figure 12. Heart Attack
Figure 13. Valsartan Report Years Considered
Figure 14. Global Valsartan Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Valsartan Revenue 2018-2034 (US$ Million)
Figure 16. Global Valsartan Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 17. Global Valsartan Revenue Market Share by Region (2018-2034)
Figure 18. Global Valsartan Sales 2018-2034 ((K Units)
Figure 19. Global Valsartan Sales Market Share by Region (2018-2034)
Figure 20. US & Canada Valsartan Sales YoY (2018-2034) & (K Units)
Figure 21. US & Canada Valsartan Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Valsartan Sales YoY (2018-2034) & (K Units)
Figure 23. Europe Valsartan Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Valsartan Sales YoY (2018-2034) & (K Units)
Figure 25. China Valsartan Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Asia (excluding China) Valsartan Sales YoY (2018-2034) & (K Units)
Figure 27. Asia (excluding China) Valsartan Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Valsartan Sales YoY (2018-2034) & (K Units)
Figure 29. Middle East, Africa and Latin America Valsartan Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Valsartan Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Valsartan in the World: Market Share by Valsartan Revenue in 2022
Figure 32. Global Valsartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Valsartan Sales Market Share by Type (2018-2034)
Figure 34. Global Valsartan Revenue Market Share by Type (2018-2034)
Figure 35. Global Valsartan Sales Market Share by Application (2018-2034)
Figure 36. Global Valsartan Revenue Market Share by Application (2018-2034)
Figure 37. US & Canada Valsartan Sales Market Share by Type (2018-2034)
Figure 38. US & Canada Valsartan Revenue Market Share by Type (2018-2034)
Figure 39. US & Canada Valsartan Sales Market Share by Application (2018-2034)
Figure 40. US & Canada Valsartan Revenue Market Share by Application (2018-2034)
Figure 41. US & Canada Valsartan Revenue Share by Country (2018-2034)
Figure 42. US & Canada Valsartan Sales Share by Country (2018-2034)
Figure 43. U.S. Valsartan Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Valsartan Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Valsartan Sales Market Share by Type (2018-2034)
Figure 46. Europe Valsartan Revenue Market Share by Type (2018-2034)
Figure 47. Europe Valsartan Sales Market Share by Application (2018-2034)
Figure 48. Europe Valsartan Revenue Market Share by Application (2018-2034)
Figure 49. Europe Valsartan Revenue Share by Country (2018-2034)
Figure 50. Europe Valsartan Sales Share by Country (2018-2034)
Figure 51. Germany Valsartan Revenue (2018-2034) & (US$ Million)
Figure 52. France Valsartan Revenue (2018-2034) & (US$ Million)
Figure 53. U.K. Valsartan Revenue (2018-2034) & (US$ Million)
Figure 54. Italy Valsartan Revenue (2018-2034) & (US$ Million)
Figure 55. Russia Valsartan Revenue (2018-2034) & (US$ Million)
Figure 56. China Valsartan Sales Market Share by Type (2018-2034)
Figure 57. China Valsartan Revenue Market Share by Type (2018-2034)
Figure 58. China Valsartan Sales Market Share by Application (2018-2034)
Figure 59. China Valsartan Revenue Market Share by Application (2018-2034)
Figure 60. Asia Valsartan Sales Market Share by Type (2018-2034)
Figure 61. Asia Valsartan Revenue Market Share by Type (2018-2034)
Figure 62. Asia Valsartan Sales Market Share by Application (2018-2034)
Figure 63. Asia Valsartan Revenue Market Share by Application (2018-2034)
Figure 64. Asia Valsartan Revenue Share by Region (2018-2034)
Figure 65. Asia Valsartan Sales Share by Region (2018-2034)
Figure 66. Japan Valsartan Revenue (2018-2034) & (US$ Million)
Figure 67. South Korea Valsartan Revenue (2018-2034) & (US$ Million)
Figure 68. China Taiwan Valsartan Revenue (2018-2034) & (US$ Million)
Figure 69. Southeast Asia Valsartan Revenue (2018-2034) & (US$ Million)
Figure 70. India Valsartan Revenue (2018-2034) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Valsartan Sales Market Share by Type (2018-2034)
Figure 72. Middle East, Africa and Latin America Valsartan Revenue Market Share by Type (2018-2034)
Figure 73. Middle East, Africa and Latin America Valsartan Sales Market Share by Application (2018-2034)
Figure 74. Middle East, Africa and Latin America Valsartan Revenue Market Share by Application (2018-2034)
Figure 75. Middle East, Africa and Latin America Valsartan Revenue Share by Country (2018-2034)
Figure 76. Middle East, Africa and Latin America Valsartan Sales Share by Country (2018-2034)
Figure 77. Brazil Valsartan Revenue (2018-2034) & (US$ Million)
Figure 78. Mexico Valsartan Revenue (2018-2034) & (US$ Million)
Figure 79. Turkey Valsartan Revenue (2018-2034) & (US$ Million)
Figure 80. Israel Valsartan Revenue (2018-2034) & (US$ Million)
Figure 81. GCC Countries Valsartan Revenue (2018-2034) & (US$ Million)
Figure 82. Valsartan Value Chain
Figure 83. Valsartan Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed